Poor prognosis in estrogen receptor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

Cell Line, Tumor Uterus Tumor Cells, Cultured Cell Nucleus Breast MCF-7 Cells Endometrium Cytosol Cells, Cultured Ovary Mammary Glands, Animal Oviducts Cell Line Epithelial Cells Cytoplasm Lymph Nodes HeLa Cells Stromal Cells COS Cells

Organisms4

Mice, Nude Rats, Sprague-Dawley Mice, Knockout Mice, Inbred C57BL

Diseases35

Breast Neoplasms Neoplasms, Hormone-Dependent Neoplasm Invasiveness Lymphatic Metastasis Adenocarcinoma Carcinoma, Ductal, Breast Neoplasm Metastasis Disease Progression Carcinoma Neoplasm Recurrence, Local Endometrial Neoplasms Lung Neoplasms Liver Neoplasms Mammary Neoplasms, Experimental Carcinoma, Squamous Cell Ovarian Neoplasms Carcinoma, Hepatocellular Carcinoma, Lobular Stomach Neoplasms Brain Neoplasms Carcinoma, Intraductal, Noninfiltrating Recurrence Uterine Neoplasms Esophageal Neoplasms Cell Transformation, Neoplastic Colorectal Neoplasms Mammary Neoplasms, Animal Pancreatic Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms Prostatic Neoplasms Disease Models, Animal Melanoma Cholangiocarcinoma Kidney Neoplasms

Chemicals and Drugs98

Receptors, Estrogen Estrogen Receptor alpha Estrogens Estrogen Receptor beta Estradiol Selective Estrogen Receptor Modulators Tamoxifen Estrogen Receptor Modulators Estrogen Antagonists Receptors, Progesterone Estrogens, Conjugated (USP)Tumor Markers, Biological Estrogens, Non-Steroidal Estradiol Congeners Estrogens, Catechol RNA, Messenger Aromatase Receptor, erbB-2 Diethylstilbestrol Raloxifene Phytoestrogens Antineoplastic Agents, Hormonal Receptors, Estradiol Phenols Ethinyl Estradiol Vitellogenins Estrone Benzhydryl Compounds Neoplasm Proteins Receptors, Androgen Ki-67 Antigen Ligands Transcription Factors Aromatase Inhibitors Progesterone Nafoxidine Endocrine Disruptors Antineoplastic Agents Isoflavones Nuclear Receptor Coactivator 1 Charcoal Nuclear Receptor Coactivator 2 Nuclear Receptor Coactivator 3 Nitriles RNA, Small Interfering Progestins Tumor Suppressor Protein p53 DNA, Neoplasm Receptors, G-Protein-Coupled Cyclin D1 Genistein Testosterone Gonadal Steroid Hormones DNA-Binding Proteins Tumor Suppressor Proteins Dihydrotestosterone Nuclear Proteins Androgens Receptor, Epidermal Growth Factor RNA, Neoplasm Pyrazoles Protein Isoforms Methoxychlor DNA Primers Co-Repressor Proteins DNA Histone Acetyltransferases Cathepsin D Estradiol Antagonists Nuclear Receptor Coactivators Plant Preparations Biological Markers Proto-Oncogene Proteins Hydroxyestrones Propionates Proto-Oncogene Proteins c-akt Triazoles Coumestrol Luciferases Promegestone Receptors, Steroid Recombinant Fusion Proteins Polyunsaturated Alkamides Hepatocyte Nuclear Factor 3-alpha Medroxyprogesterone Acetate Cyclophosphamide Toremifene Doxorubicin Keratin-5 Antibodies, Monoclonal Trans-Activators Androstane-3,17-diol Prolactin Equol Oncogene Proteins Equilenin Repressor Proteins Estriol

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Prognosis Ovariectomy Immunohistochemistry Survival Analysis Neoplasm Staging Survival Rate Reverse Transcriptase Polymerase Chain Reaction Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Disease-Free Survival Follow-Up Studies Tissue Array Analysis Gene Expression Profiling Multivariate Analysis Blotting, Western Immunoenzyme Techniques Proportional Hazards Models Risk Factors Predictive Value of Tests Transfection Oligonucleotide Array Sequence Analysis Prospective Studies Antineoplastic Combined Chemotherapy Protocols Mammary Neoplasms, Experimental Neoplasm Grading Cohort Studies Combined Modality Therapy Chemotherapy, Adjuvant Castration Case-Control Studies Polymerase Chain Reaction Models, Biological Binding, Competitive Risk Assessment Chromatin Immunoprecipitation Real-Time Polymerase Chain Reaction Organ Size In Situ Hybridization, Fluorescence Gene Knockdown Techniques Biopsy Analysis of Variance Xenograft Model Antitumor Assays Neoadjuvant Therapy Hormone Replacement Therapy Neoplasm Transplantation Disease Models, Animal Reproducibility of Results Fatal Outcome Chi-Square Distribution Sensitivity and Specificity Transplantation, Heterologous Orchiectomy

Phenomena and Processes46

Gene Expression Regulation, Neoplastic Signal Transduction Time Factors Cell Proliferation Transcription, Genetic Postmenopause Promoter Regions, Genetic Response Elements Transcriptional Activation Gene Expression Gene Expression Regulation Drug Resistance, Neoplasm Transfection Cell Division Dose-Response Relationship, Drug Base Sequence Menopause Protein Binding Up-Regulation Apoptosis Mutation Pregnancy Down-Regulation Sex Characteristics Receptor Cross-Talk Binding Sites Phosphorylation Premenopause DNA Methylation Genes, erbB-2 Estrous Cycle Phenotype Genes, Reporter Binding, Competitive Gene Amplification Organ Size Genotype Cell Cycle Cell Movement RNA Interference Cell Survival Chi-Square Distribution Sensitivity and Specificity Kinetics Cell Growth Processes Protein Structure, Tertiary

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Survival Rate Base Sequence Molecular Sequence Data Fatal Outcome

Health Care22

Survival Analysis Survival Rate Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Disease-Free Survival Follow-Up Studies Multivariate Analysis Proportional Hazards Models Risk Factors Predictive Value of Tests Prospective Studies Cohort Studies Case-Control Studies Age Factors Risk Assessment Analysis of Variance Reproducibility of Results Fatal Outcome Chi-Square Distribution Sensitivity and Specificity Sex Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Receptors, Estrogen Estrogen Receptor alpha Estrogens Estrogen Receptor beta Prognosis Estradiol Selective Estrogen Receptor Modulators Breast Neoplasms Tamoxifen Estrogen Receptor Modulators Estrogen Antagonists Receptors, Progesterone Estrogens, Conjugated (USP)Ovariectomy Cell Line, Tumor Tumor Markers, Biological Immunohistochemistry Estrogens, Non-Steroidal Gene Expression Regulation, Neoplastic Uterus Survival Analysis Estradiol Congeners Estrogens, Catechol RNA, Messenger Aromatase Receptor, erbB-2 Diethylstilbestrol Neoplasm Staging Raloxifene Survival Rate Phytoestrogens Neoplasms, Hormone-Dependent Antineoplastic Agents, Hormonal Reverse Transcriptase Polymerase Chain Reaction Neoplasm Invasiveness Treatment Outcome Signal Transduction Kaplan-Meier Estimate Retrospective Studies Time Factors Cell Proliferation Disease-Free Survival Tumor Cells, Cultured Lymphatic Metastasis Follow-Up Studies Receptors, Estradiol Tissue Array Analysis Transcription, Genetic Adenocarcinoma Gene Expression Profiling Multivariate Analysis Carcinoma, Ductal, Breast Blotting, Western Phenols Ethinyl Estradiol Vitellogenins Postmenopause Estrone Immunoenzyme Techniques Benzhydryl Compounds Neoplasm Metastasis Promoter Regions, Genetic Neoplasm Proteins Receptors, Androgen Disease Progression Carcinoma Neoplasm Recurrence, Local Response Elements Ki-67 Antigen Transcriptional Activation Proportional Hazards Models Ligands Risk Factors Gene Expression Predictive Value of Tests Transcription Factors Cell Nucleus Aromatase Inhibitors Gene Expression Regulation Drug Resistance, Neoplasm Progesterone Breast Transfection Nafoxidine Endocrine Disruptors MCF-7 Cells Endometrial Neoplasms Antineoplastic Agents Cell Division Lung Neoplasms Isoflavones Dose-Response Relationship, Drug Nuclear Receptor Coactivator 1 Base Sequence Menopause Protein Binding Up-Regulation Apoptosis Oligonucleotide Array Sequence Analysis Charcoal

No FAQ available that match "poor prognosis in estrogen receptor"